Business Courier: UC violinist to make Carnegie Hall debut

A sophomore violinist at the University of Cincinnati’s College-Conservatory of Music is set to make her debut this month at New York City’s Carnegie Hall.

Kristine Clair Uchi “KayCee” Galano will perform the complete J.S. Bach Solo Sonatas and Partitas from memory at 7:30 p.m., Oct. 12, at Weill Recital Hall.

Originally from the Philippines, Galano, 18, studies with professor Kurt Sassmannshaus, the Dorothy Richard Starling Chair in Classical Violin. Galano's performance is presented by the Starling Project Foundation Cincinnati.

"KayCee’s affinity and love of Bach’s solo works has been a source of inspiration in her young life for many years," Sassmannshaus says. "Her captivating interpretations show the rare confluence of a youthful spirit and uncommon maturity."

Read more in the Cincinnati Business Courier.

Related Stories

1

Sugar overload killing hearts

November 10, 2025

Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.

2

Is going nuclear the solution to Ohio’s energy costs?

November 10, 2025

The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.

3

App turns smartwatch into detector of structural heart disease

November 10, 2025

An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.